ruta graveolens leaf extract

General Material Information

Preferred name	ruta graveolens leaf extract
Trivial Name	Rue, ext.
Short Description	extract obtained from the leaves of the rue, ruta graveolens l., rutaceae
CAS Number	84929-47-5
ECHA Number	284-531-5
FDA UNII	Search
Synonyms	extract obtained from the leaves of the rue, ruta graveolens l., rutaceae herb-of-grace leaf extract rue leaf extract ruta hortensis leaf extract ruta graveolens l. leaf extract Rue, ext. Ruta graveolens ext. Ruta hortensis ext.

	ruta graveolens l. leaf extract
Pubchem (sid):	135276071

Publications by PubMed
Antinociceptive, anti-inflammatory and antipyretic activities of the leaf methanol extract of Ruta graveolens L. (Rutaceae) in mice and rats.
Molecular authentication of the medicinal herb Ruta graveolens (Rutaceae) and an adulterant using nuclear and chloroplast DNA markers.
Unusually divergent 4-coumarate:CoA-ligases from Ruta graveolens L.
Saprophytic and cycloheximide resistant fungi isolated from golden hamster.
Dermatitis-inducing furanocoumarins on leaf surfaces of eight species of Rutaceous and Umbelliferous plants.
Antifertility principle of Ruta graveolens.
Determination of Furanocoumarins on the Leaf Surface of Ruta graveolens with an Improved Extraction Technique.
[Leaf extracts of Ruta graveolens L., factors in the in vitro growth of fragments of Helanthus tuberosus L. tubercles].
[Pharmacognostic study of rue leaf (Ruta graveolens) its principle components; rutoside and essence].

Wikipedia:

Material listed in food chemical codex


Hazards identification

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements

Pictogram

Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Category:
flavor and fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice
IFRA Critical Effect:
Phototoxicity
IFRA fragrance material specification:
	Where the bergapten (5-methoxypsoralen) content of all relevant oils present in a compound has been determined, it is recommended that for applications on areas of skin exposed to sunshine, excluding bath preparations, soaps and other products which are washed off the skin, the total level of bergapten in the consumer products should not exceed 0.0015% (15 ppm). This is equivalent to 0.0075% (75 ppm) in a fragrance compound used at 20% in the consumer product. Where the level of bergapten has not been determined by appropriate methods, the limits specified in the guidelines on individual oils should apply. In those cases, where such oils are used in combination with other phototoxic ingredients, the additive effect has to be taken into consideration and the use levels have to be reduced accordingly. The sum of the concentrations of all phototoxic fragrance ingredients, expressed in % of their recommended maximum level in the consumer product, shall not exceed 100.

EPA Substance Registry Services (SRS):Registry

National Institute of Allergy and Infectious Diseases:Data

ruta graveolens l. leaf extract

Chemidplus:084929475